X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (303) 303
index medicus (300) 300
cardiac & cardiovascular systems (254) 254
female (200) 200
male (198) 198
heart failure (187) 187
aged (156) 156
middle aged (147) 147
mortality (99) 99
heart failure - drug therapy (95) 95
adult (79) 79
prognosis (79) 79
treatment outcome (74) 74
abridged index medicus (70) 70
heart failure - physiopathology (68) 68
risk factors (66) 66
heart failure - mortality (64) 64
cardiac and cardiovascular systems (55) 55
kardiologi (55) 55
cardiovascular (51) 51
diagnosis (49) 49
double-blind method (48) 48
drug therapy (44) 44
outcomes (44) 44
guidelines (43) 43
aged, 80 and over (42) 42
cardiology (41) 41
heart rate (40) 40
ivabradine (40) 40
hospitalization (39) 39
chronic disease (38) 38
follow-up studies (38) 38
echocardiography (37) 37
europe (37) 37
morbidity (36) 36
adrenergic beta-antagonists - therapeutic use (35) 35
cardiomyopathy (35) 35
mutation (35) 35
hospitalization - statistics & numerical data (33) 33
survival (33) 33
clinical medicine (32) 32
genetics (32) 32
klinisk medicin (32) 32
association (31) 31
disease (31) 31
heart attacks (31) 31
heart failure - diagnosis (31) 31
benzazepines - therapeutic use (29) 29
heart failure - complications (29) 29
heart failure - therapy (29) 29
cardiovascular agents - therapeutic use (28) 28
myocardial-infarction (27) 27
stroke volume - physiology (27) 27
cardiac patients (26) 26
cardiomyopathy, hypertrophic - genetics (26) 26
internal medicine (26) 26
management (26) 26
prospective studies (26) 26
cardiovascular disease (25) 25
chronic heart failure (25) 25
pedigree (25) 25
risk (25) 25
risk assessment (25) 25
trial (24) 24
electrocardiography (23) 23
heart (23) 23
tetrazoles - therapeutic use (23) 23
coronary-artery-disease (22) 22
medical and health sciences (22) 22
medicin och hälsovetenskap (22) 22
stroke volume (22) 22
adolescent (21) 21
angiotensin-converting enzyme inhibitors - therapeutic use (21) 21
clinical trials (21) 21
kaplan-meier estimate (21) 21
left-ventricular dysfunction (21) 21
population (21) 21
time factors (21) 21
cardiology and cardiovascular medicine (20) 20
heart failure - epidemiology (20) 20
prevalence (20) 20
proportional hazards models (20) 20
angiotensin ii type 1 receptor blockers - therapeutic use (19) 19
cardiomyopathy, dilated - genetics (19) 19
care and treatment (19) 19
dilated cardiomyopathy (19) 19
genotype (19) 19
heart rate - drug effects (19) 19
preserved ejection fraction (19) 19
therapy (19) 19
analysis (18) 18
atrial fibrillation (18) 18
biphenyl compounds - therapeutic use (18) 18
hypertrophic cardiomyopathy (18) 18
patient outcomes (18) 18
practice guidelines as topic (18) 18
randomized controlled trials as topic (18) 18
shift (18) 18
blood pressure (17) 17
epidemiology (17) 17
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (492) 492
French (38) 38
Spanish (6) 6
Portuguese (4) 4
Italian (2) 2
Croatian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Heart Journal, ISSN 0195-668X, 01/2016, Volume 37, Issue 4, pp. 365 - 374
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 06/2017, Volume 19, Issue 6, pp. 810 - 810
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 01/2017, Volume 19, Issue 1, pp. 78 - 79
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9744, pp. 875 - 885
Journal Article
European heart journal, ISSN 0195-668X, 01/2015, Volume 36, Issue 2, pp. 63 - 64
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9744, pp. 886 - 894
Summary Background Raised resting heart rate is a marker of cardiovascular risk. We postulated that heart rate is also a risk factor for cardiovascular events... 
Internal Medicine | RATE REDUCTION | HUMAN MYOCARDIUM | MEDICINE, GENERAL & INTERNAL | SYSTOLIC DYSFUNCTION BEAUTIFUL | CARDIOVASCULAR-DISEASE | DOUBLE-BLIND | ATHEROSCLEROSIS | CORONARY-ARTERY-DISEASE | BETA-BLOCKER | IVABRADINE | LEFT-VENTRICULAR FUNCTION | Benzazepines - adverse effects | Humans | Middle Aged | Heart Failure - physiopathology | Male | Sinoatrial Node - drug effects | Heart Rate - drug effects | Electrocardiography | Adult | Female | Heart Failure - mortality | Severity of Illness Index | Heart Failure - complications | Cardiovascular Agents - administration & dosage | Double-Blind Method | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Heart Failure - drug therapy | Cardiovascular Agents - therapeutic use | Benzazepines - therapeutic use | Aged | Benzazepines - administration & dosage | Cardiovascular Agents - adverse effects | Chronic Disease | Heart failure | Prevention | Heart beat | Dosage and administration | Drug therapy | Health aspects | Risk factors | Cardiovascular agents | Studies | Heart rate | Cardiovascular disease | Mortality | Index Medicus | Abridged Index Medicus | Cardiovascular diseases | use | Sinoatrial Node/drug effects | Heart Failure/complications/drug therapy/mortality/physiopathology | Kardiologi | Cardiac and Cardiovascular Systems | Benzazepines/administration & dosage/adverse effects/therapeutic use | Heart Rate/drug effects | Cardiovascular Agents/administration & dosage/adverse effects/therapeutic | Kaplan-Meiers Estimate
Journal Article
Circulation Journal, ISSN 1346-9843, 2015
The management of chronic heart failure (HF) with low ejection fraction (EF) has changed considerably over the past 30 years: the introduction of... 
Heart failure | Dual inhibitors | Implantable cardiac defibrillators | Cardiac resynchronization therapy
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9681, pp. 2125 - 2135
Summary Background Rosiglitazone is an insulin sensitiser used in combination with metformin, a sulfonylurea, or both, for lowering blood glucose in people... 
Internal Medicine | CARDIAC OUTCOMES | METFORMIN | MEDICINE, GENERAL & INTERNAL | MONOTHERAPY | MYOCARDIAL-INFARCTION | SULFONYLUREAS | HEART-ASSOCIATION | RISK | COMPLICATIONS | BLOOD-GLUCOSE CONTROL | FAILURE | Glycated Hemoglobin A - analysis | Myocardial Infarction - mortality | Body Weight | Metformin - therapeutic use | Prospective Studies | Humans | Middle Aged | Fractures, Bone - epidemiology | Hospitalization - statistics & numerical data | Male | Drug Utilization | Thiazolidinediones - therapeutic use | Cholesterol, LDL - blood | Female | Stroke - mortality | Drug Therapy, Combination | Heart Failure - epidemiology | Hypoglycemic Agents - therapeutic use | Administration, Oral | Sulfonylurea Compounds - therapeutic use | Angina, Unstable - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Sex Factors | Cholesterol, HDL - blood | Diuretics - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Neoplasms - epidemiology | Type 2 diabetes | Patient outcomes | Dosage and administration | Drug therapy, Combination | Research | Metformin | Rosiglitazone maleate | Drug therapy | Health aspects | Heart failure | Studies | Clinical trials | Data collection | Blood pressure | Diabetes | Marketing | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Journal Article
Journal Article